Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Alan Nierenberg, M.D.

Co-Author

This page shows the publications co-authored by Andrew Nierenberg and Dustin Rabideau.
Connection Strength

2.792
  1. Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome. J Psychiatr Res. 2021 08; 140:205-213.
    View in: PubMed
    Score: 0.242
  2. Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. J Affect Disord. 2019 12 01; 259:164-172.
    View in: PubMed
    Score: 0.214
  3. Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial. J Affect Disord. 2018 01 01; 225:563-568.
    View in: PubMed
    Score: 0.186
  4. Clinical correlates of acute bipolar depressive episode with psychosis. J Affect Disord. 2017 08 01; 217:29-33.
    View in: PubMed
    Score: 0.181
  5. Poor quality of life and functioning in bipolar disorder. Int J Bipolar Disord. 2017 Dec; 5(1):10.
    View in: PubMed
    Score: 0.181
  6. Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study. J Affect Disord. 2016 Nov 15; 205:159-164.
    View in: PubMed
    Score: 0.172
  7. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder. J Clin Psychiatry. 2016 Jan; 77(1):90-9.
    View in: PubMed
    Score: 0.166
  8. A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report. J Affect Disord. 2016 Mar 01; 192:212-8.
    View in: PubMed
    Score: 0.166
  9. A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial. Clin Trials. 2014 Aug; 11(4):494-502.
    View in: PubMed
    Score: 0.149
  10. Use of treatment services in a comparative effectiveness study of bipolar disorder. Psychiatr Serv. 2013 Nov 01; 64(11):1119-26.
    View in: PubMed
    Score: 0.143
  11. Medication adherence in a comparative effectiveness trial for bipolar disorder. Acta Psychiatr Scand. 2014 May; 129(5):359-65.
    View in: PubMed
    Score: 0.142
  12. Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder. J Affect Disord. 2013 Nov; 151(2):722-727.
    View in: PubMed
    Score: 0.141
  13. The Medication Recommendation Tracking Form: a novel tool for tracking changes in prescribed medication, clinical decision making, and use in comparative effectiveness research. J Psychiatr Res. 2013 Nov; 47(11):1686-93.
    View in: PubMed
    Score: 0.140
  14. Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale. J Affect Disord. 2019 03 01; 246:126-131.
    View in: PubMed
    Score: 0.051
  15. Corrigendum to bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study [Journal of Affective Disorders 217 (2017) 183-189]. J Affect Disord. 2018 01 01; 225:775-777.
    View in: PubMed
    Score: 0.046
  16. Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. J Affect Disord. 2017 08 01; 217:183-189.
    View in: PubMed
    Score: 0.045
  17. Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study. J Clin Psychiatry. 2016 Jan; 77(1):100-8.
    View in: PubMed
    Score: 0.042
  18. A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR). J Psychiatr Res. 2015 Dec; 71:126-33.
    View in: PubMed
    Score: 0.041
  19. Patient perceptions of physical health and bipolar symptoms: The intersection of mental and physical health. J Affect Disord. 2016 Jan 01; 189:203-6.
    View in: PubMed
    Score: 0.041
  20. Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder. Acta Psychiatr Scand. 2016 Feb; 133(2):144-153.
    View in: PubMed
    Score: 0.040
  21. An exploratory study of responses to low-dose lithium in African Americans and Hispanics. J Affect Disord. 2015 Jun 01; 178:224-8.
    View in: PubMed
    Score: 0.039
  22. Psychotherapy use in bipolar disorder: Association with functioning and illness severity. Aust N Z J Psychiatry. 2015 May; 49(5):453-61.
    View in: PubMed
    Score: 0.039
  23. Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study. J Clin Psychopharmacol. 2015 Feb; 35(1):68-74.
    View in: PubMed
    Score: 0.039
  24. The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder. J Affect Disord. 2014 Dec; 169:144-8.
    View in: PubMed
    Score: 0.038
  25. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disord. 2015 Mar; 17(2):212-23.
    View in: PubMed
    Score: 0.038
  26. Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial. J Affect Disord. 2014 Jun; 161:30-5.
    View in: PubMed
    Score: 0.037
  27. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand. 2014 Jan; 129(1):24-34.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.